PACB News and Press, Pacific Biosciences of California Inc.

2024-07-02 11:20:47 ET Summary This article will outline nine steps I use to identify the most promising pharmaceutical companies and avoid investment pitfalls. In addition, each of the nine steps will provide examples of various factors and how they influence the assessment of th...

2024-06-27 10:17:45 ET Information Technology has been the best performing name among all 11 S&P 500 ( SP500 ) sectors in the first half of 2024, but Cathie Wood’s actively managed ARK Innovation ETF ( NYSEARCA: ARKK ) - which aims to provide investors exposure to dis...

2024-06-13 10:12:34 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips We are almost halfway through 2024, and the stock market is putting on a masterclass performance. The S&P 500 is up 12% year-to-date after rising 23% last year. Back-to-back years of do...

PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database PR Newswire Consortium Delivers Publicly Available Datasets that Enrich Detection of Rare and Novel Genetic Variants for Advances in Human Disease Research ...

2024-06-03 04:25:05 ET Summary Pacific Biosciences' SMRT sequencing has higher error rates (or so the perception goes) than Illumina's, which has an impact on cost and time efficiency. Despite efforts to improve perceptions around its sequencing accuracy, Pacific still faces appar...

2024-05-23 08:48:04 ET Greenwave Technology Solutions ( GWAV ) +55% after eliminates all convertible debt . Ascent Solar Technologies ( ASTI ) +49% . Bicycle Therapeutics ( BCYC ) +14% after announces $555 million private placement equity financing ...

Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases PR Newswire Consortium Selects Leading Genomics Companies to Support Pediatric Mendelian Genomics Research Center Program ...

2024-05-13 14:15:02 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for PACB on May 13, 2024 12:08PM ET. The previous analyst recommendation was Equal-Weight. PACB was trading at $1.975 at issue of the analyst recommendation. The overall analyst consensus : ...

2024-05-13 14:00:03 ET Tejas Savant from Morgan Stanley issued a price target of $4.00 for PACB on 2024-05-13 12:08:00. The adjusted price target was set to $4.00. At the time of the announcement, PACB was trading at $1.975. The overall price target consensus is at $2.50...

2024-05-13 13:07:36 ET More on GameStop: GameStop: Approaching An Optimistic Fair Value But Not There Yet GameStop: Operations Are Stabilizing, But Expect More Pain To Come GameStop: Compelling Risk To Reward Profile Ahead Of Q4 Earnings GameStop's sudden mem...